Back to Search Start Over

DEL-Thyroid: deep ensemble learning framework for detection of thyroid cancer progression through genomic mutation.

Authors :
Shah, Asghar Ali
Daud, Ali
Bukhari, Amal
Alshemaimri, Bader
Ahsan, Muhammad
Younis, Rehmana
Source :
BMC Medical Informatics & Decision Making; 7/22/2024, Vol. 24 Issue 1, p1-15, 15p
Publication Year :
2024

Abstract

Genes, expressed as sequences of nucleotides, are susceptible to mutations, some of which can lead to cancer. Machine learning and deep learning methods have emerged as vital tools in identifying mutations associated with cancer. Thyroid cancer ranks as the 5th most prevalent cancer in the USA, with thousands diagnosed annually. This paper presents an ensemble learning model leveraging deep learning techniques such as Long Short-Term Memory (LSTM), Gated Recurrent Units (GRUs), and Bi-directional LSTM (Bi-LSTM) to detect thyroid cancer mutations early. The model is trained on a dataset sourced from asia.ensembl.org and IntOGen.org, consisting of 633 samples with 969 mutations across 41 genes, collected from individuals of various demographics. Feature extraction encompasses techniques including Hahn moments, central moments, raw moments, and various matrix-based methods. Evaluation employs three testing methods: self-consistency test (SCT), independent set test (IST), and 10-fold cross-validation test (10-FCVT). The proposed ensemble learning model demonstrates promising performance, achieving 96% accuracy in the independent set test (IST). Statistical measures such as training accuracy, testing accuracy, recall, sensitivity, specificity, Mathew's Correlation Coefficient (MCC), loss, training accuracy, F1 Score, and Cohen's kappa are utilized for comprehensive evaluation. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14726947
Volume :
24
Issue :
1
Database :
Complementary Index
Journal :
BMC Medical Informatics & Decision Making
Publication Type :
Academic Journal
Accession number :
178559898
Full Text :
https://doi.org/10.1186/s12911-024-02604-1